References
- Atkinson A.B., Robertson J.I.S. Captopril in the treatment of clinical hypertension and cardiac failure Lancet 2: 836–839, 1979.
- Barnes J.N., Davies E.S., Gent C.B. Rash, eosinophilia, and hyperkalaemia associated with enalapril. Lancet 2: 41–42, 1983.
- Crantz F.R., Swartz S.L., Hollenberg N.K., Moore T.J., Dluhy R.G., Levine L., Williams G.H. Role of prostaglandins in the hypertensive response to captopril in essential hypertension. Clin. Res. 27: 592A, 1979.
- Editorial. Captopril: Benefits and risks in severe hypertension. Lancet 2: 129–130, 1980.
- Fassett R.G., Walker R.G., Whitworth J.A., Kincaid-Smith P. Repeated renal failure with captopril. Br. Med. J. 286; 648, 1983.
- Gavras I., Gavras H. Captopril and enalapril. Ann. Int. Med. 98(4): 556–557, 1983.
- McNeil J.J., Anderson A., Christophidis N., Jarrott B., Louis W.J. Taste loss associated with oral captopril treatment. Lancet 2:1555–1556, 1979.
- Meggs L.H., Hollenberg N.K., Converting enzyme inhibition and the kidney. Hypertension 2: 551–557, 1980.
- Murthy V.S., Waldron T.L., Goldberg M.E. The mechanism of bradykinin potention after inhibition of angiotensin-converting-enzyme by SQ 14.225 in conscious rabbits. Circ. Res. 43 (suppl I): 1–40, 1978.
- Nasjletti A., Colina-Chourio J., McGiff J. Disappearance of bradykinin in the renal circulation of dogs. Effects of kininase inhibition. Circ. Res. 37: 59, 1975.
- Wilkin J.K., Hammond J.J., Kirkendall W.M. The captopril-induced eruption. Arch. Dermatol 116: 902–905, 1980.